Medical Digest & Congress Report

Professor Virginia Kaklamani speak about the novelties and state of the art treatment presented at SABCS 2021. Video: https://congressreport.eu/scientific-contents/interview:highlights-san-antonio-breast-cancer-symposium-2021

Professor Susanne Saussele speaks about antibody response to vaccination with BNT162b2, mRNA-1273, and ChADOx1 in Patients with Myeloid and Lymphoid Neoplasms. In general, patients with hematological diseases are predisposed to develop infections. Severe COVID-19 infection associated with high mortality is more likely in these patient cohorts compared to the general population. Due to immune defec...

Professor Javier Cortes speaks about the final results of KEYNOTE-355 trial, a Randomized, double-blind, phase 3 study of pembrolizumab + chemotherapy vs placebo + chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer. Video: https://congressreport.eu/scientific-contents/interview:final-results-keynote-355

Professor Manali Kamdar speaks about Lisocabtagene Maraleucel, a CD19-Directed Chimeric Antigen Receptor T Cell Therapy, Versus Standard of Care with Salvage Chemotherapy Followed By Autologous Stem Cell Transplantation As Second-Line Treatment in Patients with Relapsed or Refractory Large B-Cell Lymphoma. Video: https://congressreport.eu/scientific-contents/interview:results-randomized-phase-3-tr...

The main topics that Professor Umberto Vitolo speaks about: CAR T-cell studies, POLARIS study, R-CHOP timing. Video: https://congressreport.eu/scientific-contents/interview:novelties-treatment-non-hodgkin-lymphoma-2021

Professor Lisa A. Carey speaks about the MONALEESA-2, -3, and -7 trials of ribociclib + endocrine therapy in patients with HR+/HER2− advanced breast cancer. Video: https://congressreport.eu/scientific-contents/interview:correlative-analysis-overall-survival-intrinsic-subtype-across-monaleesa-2-3-and-7-studies

Professor Michael Gnant speaks about the final results from 5,760 patients in the randomized phase III PALLAS trial. Video: https://congressreport.eu/scientific-contents/interview:pallas-trial-adjuvant-palbociclib-hrher2-early-breast-cancer

Professor Sara Hurvitz speaks about trastuzumab deruxtecan vs. trastuzumab emtansine in patients with HER2+ metastatic breast cancer. Video: https://congressreport.eu/scientific-contents/interview:destiny-breast03-trial

Prof. Roman Vangoitsenhoven speaks about a newly published research paper in Obesity Facts sheds light on the real-world effectiveness and practicality of the liraglutide treatment. Video: https://congressreport.eu/scientific-contents/standalonecontent:liraglutide-weight-management-real-world

Dr. Alexander Miras is a senior lecturer and consultant in endocrinology at Imperial College London, known expert in the field of pediatric medicine. Video: https://congressreport.eu/scientific-contents/standalonecontent:clinical-impact-liraglutide-treatment-obesity

Prof. Michael A. Nauck has a long clinical experience with GLP-1 analogs, author of several scientific papers about their applications.  Video: https://congressreport.eu/scientific-contents/standalonecontent:role-glp-1-receptor-agonists-weight-reduction-and-cardiovascular-risk-reduction

Prof. Mikael Rydén speak about the state-of-the-art treatment of the disease. Video: https://congressreport.eu/scientific-contents/interview:current-guidelines-diabetes-management

Prof. Brian Frier speak about the latest findings on the treatment of the disease. Video: https://congressreport.eu/scientific-contents/interview:current-guidelines-diabetes-management

Prof. Christoph Wanner speaks about the latest guidelines and findings on treatment and comprehensive care for diabetes. Video: https://congressreport.eu/scientific-contents/interview:current-guidelines-diabetes-management

Prof. Gabriel N. Hortobagyi speaks about the overall survival results from the phase III MONALEESA-2 trial of postmenopausal patients with hormone receptor positive/human epidermal growth factor receptor 2 negative advanced breast cancer treated with endocrine therapy ± ribociclib. Video: https://congressreport.eu/scientific-contents/interview:monaleesa-2-trial

Prof. Peter Galle speaks about the  the emerging therapies on advanced RCC, HCC and DTC. Video: https://congressreport.eu/scientific-contents/interview:spotlight-emerging-therapies-multidisciplinary-discussions-advanced-rcc-hcc-and-dtc

Prof. David F. McDermott speaks about the long-term survival of patients with kidney cancer. Video: https://congressreport.eu/scientific-contents/interview:should-cure-be-reasonable-goal-arcc

Prof. Jason J. Luke speaks about the efficacy and safety results from the  Keynote 716 double-blinded phase III trial. Pembrolizumab versus placebo after complete resection of high-risk stage II melanoma.  Video: https://congressreport.eu/scientific-contents/interview:keynote-716-trial

Prof. Alessandra Curioni speaks about the update of CheckMate 743 trial. Video: https://congressreport.eu/scientific-contents/interview:unresectable-malignant-pleural-mesothelioma-new-frontier-i-o

Prof. Solange Peters speaks about the most important presentations on ESMO 2021. Video: https://congressreport.eu/scientific-contents/interview:highlights-esmo-2021-congress

Prof. Wolfgang Janni speaks about the HER2CLIMB study. Video: https://congressreport.eu/scientific-contents/interview:navigating-new-era-her2-metastatic-breast-cancer-focus-her2climb-2

Prof. Gerhardt Attard speaks about the STAMPEDE study: Abiraterone acetate and prednisolone or AAP and enzalutamide added to androgen deprivation therapy for men with high-risk locally advanced prostate cancer. Video: https://congressreport.eu/scientific-contents/interview:metastases-free-survival-results-stampede-trial

Prof. Judy King speaks about the treatment of HER2+ Metastatic Breast Cancer. Video: https://congressreport.eu/scientific-contents/interview:navigating-new-era-her2-metastatic-breast-cancer-focus-her2climb

Prof. Frank Visseren speaks about the 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Video: https://congressreport.eu/scientific-contents/interview:2021-esc-guidelines-cvd-prevention

Professor Bruce Neal introduce the Salt Substitute and Stroke Study, which defines the overall balance of benefits and risks of salt substitutes compared with salt in terms of cardiovascular disease, including strokes and mortality. Video: https://congressreport.eu/scientific-contents/interview:ssass-salt-substitute-and-stroke-study-effect-salt-substitutes-cardiovascular-events-and-death